Results 121 to 130 of about 33,059 (231)
Técnica “Buddy wire” en implantación de válvula aórtica transcatéter con válvula expandible con balón: una opción de rescate en casos con implantación directa de válvula (sin predilatación) [PDF]
, 2016 not availableRicardo Allende, Rishi Puri, Éric Dumont, María del Trigo, Omar Abdul-Jawad Altisent, Josep Rodés ...Allende, R., Altisent, O.-J., del Trigo, M., Dumont, É., Puri, R., Rodés-Cabau, J. +5 morecore +1 more sourceThe pulmonary artery pulsatility index in patients with severe aortic stenosis undergoing valve replacement
ESC Heart Failure, EarlyView.Abstract Background and aims
The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...Laura A. Rechsteiner, Lukas Weber, Philipp K. Haager, Johannes Rigger, Joannis Chronis, Peter Ammann, Roman Brenner, Martin O. Schmiady, Hans Rickli, Micha T. Maeder +9 morewiley +1 more sourceAetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE‐TR registry
European Journal of Heart Failure, EarlyView.Aetiological phenotypes of secondary tricuspid regurgitation. AF, atrial fibrillation; HFpE, heart failure with preserved ejection fraction; CARE‐TR, Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure and Valve Clinics; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFrEF, heart failure ...Laura Lupi, Elena Antonioli, Angelica Praderio, Alessandro Villaschi, Elisa Soranzo, Nicola Saccani, Kamil Stankowski, Daniele Cocianni, Beniamino Pagliaro, Valeria Magni, Marco Loffi, Daniela Tomasoni, Matteo Pagnesi, Antonio Mangieri, Davide Stolfo, Gianfranco Sinagra, Marianna Adamo, Marco Metra +17 morewiley +1 more sourceTAVI: Transcatheter Aortic Valve Implantation
Methodist DeBakey Cardiovascular Journal, 2011 Introduction Aortic valvular stenosis is a disease with a long latent period followed by rapid progression to death after the onset of symptoms. The classic series by Ross and Braunwald reports an average survival of 2 to 5 years after symptom onset (Figure 1).1 There is no medical therapy proven to extend survival.Michael J. Reardon, Neal S. Kleimanopenaire +3 more sourcesEmployment of artificial intelligence for an unbiased evaluation regarding the recovery of right ventricular function after mitral valve transcatheter edge‐to‐edge repair
European Journal of Heart Failure, EarlyView.Impact of mitral transcatheter edge‐to‐edge repair (M‐TEER) on left and right heart function. IQR, interquartile range; LA, left atrial; RVEF, right ventricular ejection fraction; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion. Abstract Aims
Long‐standing severe mitral regurgitation (MR) leads to left atrial Vera Fortmeier, Amelie Hesse, Teresa Trenkwalder, Márton Tokodi, Attila Kovács, Elena Rippen, Jule Tervooren, Michelle Fett, Gerhard Harmsen, Shinsuke Yuasa, Moritz Kühlein, Héctor Alfonso Alvarez Covarrubias, Moritz von Scheidt, Ferdinand Roski, Muhammed Gerçek, Tibor Schuster, N. Patrick Mayr, Erion Xhepa, Karl‐Ludwig Laugwitz, Michael Joner, Volker Rudolph, Mark Lachmann +21 morewiley +1 more sourcePercutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis [PDF]
, 2002 Alain Cribier, Hélène Eltchaninoff, Assaf Bash, Nicolas Borenstein, Christophe Tron, Fabrice Bauer, Geneviève Dérumeaux, Frédéric Anselme, F Laborde, Martin B. Leon +9 moreopenalex +1 more sourceTranscatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts [PDF]
, 2017 OBJECTIVES While transcatheter aortic valve implantation (TAVI) has rapidly evolved for the treatment of aortic valve disease, the currently used bioprostheses are prone to continuous calcific degeneration.Behr, Luc, Bettex, Dominique, Emmert, Maximilian Y., Falk, Volkmar, Frauenfelder, Thomas, Grünenfelder, Jürg, Hoerstrup, Simon P., Sammut, Sebastien, Scherman, Jacques, Weber, Benedikt, Wolint, Petra +10 morecore Rationale and design of the TRIC‐I‐HF‐DZHK24 (TRICuspid Intervention in Heart Failure) trial
European Journal of Heart Failure, EarlyView.Study overview of the TRIC‐I‐HF‐DZHK24 trial. HF, heart failure; HFH, heart failure hospitalization; QoL, quality of life; RHC, right heart catheterization; TR, tricuspid regurgitation; TTVI, transcatheter tricuspid valve intervention. Abstract Aims
Tricuspid regurgitation (TR) is a detrimental disease frequently diagnosed in patients with right‐sided ...Thomas J. Stocker, Tobias Geisler, Wolfgang Rottbauer, Edith Lubos, Christian Frerker, Niklas Schofer, Johanne Frank, Ralph Stephan von Bardeleben, Tobias Kister, Rico Osteresch, Alexander Lauten, Tienush Rassaf, Jürgen Rothe, David M. Leistner, Lukas Stolz, Victoria Kehl, Maria Grzeschniok, Andreas Hagendorff, Volker Rudolph, Stephan Baldus, Philipp Lurz, Steffen Massberg, Jörg Hausleiter, for the TRIC‐I‐HF‐DZHK24 Investigators, Jörg Hausleiter, Thomas J. Stocker, Steffen Massberg, Lukas Stolz, Michael Näbauer, Ludwig Weckbach, Philipp Doldi, Julia Novotny, Tobias Geisler, Meinrad Gawaz, Andreas Goldschmidt, Monika Zdanyte, Wolfgang Rottbauer, Mirjam Keßler, Edith Lubos, Christian Frerker, Roza Saraei, Ingo Eitel, Tobias Schmidt, Thomas Stiermaier, Momir Dejanovikj, Sebastian Kupp, Mulham Alhagi, Niklas Schofer, Daniel Kalbacher, Johanne Frank, Derk Frank, Matthias Lutz, Mohammed Saad, Stephan von Bardeleben, Philipp Lurz, Tobias Ruf, Theresa Gößler, Volker Rudolph, Kai Peter Friedrichs, Tanja Rudolph, Maria Ivannikova, Werner Scholtz, Hazem Omran, Tobias Kister, Holger Thiele, Rico Osteresch, Rainer Hambrecht, Alexander Lauten, Tienush Rassaf, Amir A. Mahabadi, Jürgen Rothe, Christian Besler, Mirjam Wild, Dirk Westermann, Nikolaus Löffelhardt, Roman Pfister, Stephan Baldus, Christos Iliadis, Dennis Mehrkens, Erion Xhepa, Michael Joner, Teresa Trenkwalder, Hector A. Covarrubias, Friederike Schürmann, Heribert Schunkert, David Leistner, Amin Polzin, Malte Kelm, Patrick Horn, Ralf Westenfeld, Eike Tigges, Georg Nickenig, Marcel Weber, Margarita Schulz, Johanna Vogelhuber, Dominik Nelles, Christian Butter, Mathias Konstandin, Norbert Frey, Philipp Nikolai, Raffi Bekeredjian, Alexander Wolf, Marc M. Vorpahl, Ulf Landmesser, Markus Reinthaler Fabian Barbieri, Joachim Schofer, Christina Brinkmann, Bernhard Unsöld, Kerstin Piayda, Sven Möbius‐Winkler, Christian Schulze +110 morewiley +1 more sourceFirst-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIRE I Study
Structural HeartBackground: The ALLEGRA (Biosensors International) transcatheter heart valve is a self-expanding supra-annular bovine pericardial aortic valve. A new delivery system (IMPERIA™, Biosensors International) has been designed which allows the valve to be ...José Antonio Baz, MD, Christof Burgdorf, MD, Christian Frerker, MD, Ignacio Cruz González, MD, Joan Antoni Gômez, MD, Joseph Graham, MD, José Maria Hernândez, MD, Pilar Jimenez, MD, Claire B. Ren, MD, Ernest Spitzer, MD, Pim Tonino, MD, Pieter Vriesendorp, MD, Nicolas van Mieghem, MD, Samuel Copt, PhD, Anders Jönsson, MD, Keith G. Oldroyd, MD, Nicolas Doll, MD +16 moredoaj +1 more source